161 related articles for article (PubMed ID: 1905786)
1. Acquired immunity and epidemiology of Schistosoma haematobium.
Woolhouse ME; Taylor P; Matanhire D; Chandiwana SK
Nature; 1991 Jun; 351(6329):757-9. PubMed ID: 1905786
[TBL] [Abstract][Full Text] [Related]
2. Cluster analysis of schistosome-specific antibody responses partitions the population into distinct epidemiological groups.
Mutapi F; Mduluza T; Roddam AW
Immunol Lett; 2005 Jan; 96(2):231-40. PubMed ID: 15585328
[TBL] [Abstract][Full Text] [Related]
3. The epidemiology, immunology and morbidity of Schistosoma haematobium infections in diverse communities in Zimbabwe. I. The study design.
Hagan P; Chandiwana S; Ndhlovu P; Woolhouse M; Dessein A
Trop Geogr Med; 1994; 46(4 Spec No):227-32. PubMed ID: 7825225
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology of mixed Schistosoma mansoni and Schistosoma haematobium infections in northern Senegal.
Meurs L; Mbow M; Vereecken K; Menten J; Mboup S; Polman K
Int J Parasitol; 2012; 42(3):305-11. PubMed ID: 22366733
[TBL] [Abstract][Full Text] [Related]
5. Human IgE, IgG4 and resistance to reinfection with Schistosoma haematobium.
Hagan P; Blumenthal UJ; Dunn D; Simpson AJ; Wilkins HA
Nature; 1991 Jan; 349(6306):243-5. PubMed ID: 1898985
[TBL] [Abstract][Full Text] [Related]
6. Helminth- and Bacillus Calmette-Guérin-induced immunity in children sensitized in utero to filariasis and schistosomiasis.
Malhotra I; Mungai P; Wamachi A; Kioko J; Ouma JH; Kazura JW; King CL
J Immunol; 1999 Jun; 162(11):6843-8. PubMed ID: 10352306
[TBL] [Abstract][Full Text] [Related]
7. Immuno-epidemiology of human Schistosoma haematobium infection: preferential IgG3 antibody responsiveness to a recombinant antigen dependent on age and parasite burden.
Mutapi F; Mduluza T; Gomez-Escobar N; Gregory WF; Fernandez C; Midzi N; Maizels RM
BMC Infect Dis; 2006 Jun; 6():96. PubMed ID: 16764709
[TBL] [Abstract][Full Text] [Related]
8. A recombinant protein from Schistosoma mansoni useful for the detection of S. mansoni and Schistosoma haematobium antibodies.
Hancock K; Mohamed YB; Haichou X; Noh J; Dotson EM; Tsang VC
J Parasitol; 1997 Aug; 83(4):612-8. PubMed ID: 9267400
[TBL] [Abstract][Full Text] [Related]
9. Associations between specific antibody responses and resistance to reinfection in a Senegalese population recently exposed to Schistosoma mansoni.
Vereecken K; Naus CW; Polman K; Scott JT; Diop M; Gryseels B; Kestens L
Trop Med Int Health; 2007 Mar; 12(3):431-44. PubMed ID: 17313515
[TBL] [Abstract][Full Text] [Related]
10. Biological and morphological changes in worms in mixed infection of Schistosoma mansoni and S. haematobium in hamsters.
el-Assal FM; el-Nahal HM; el-Garhy ME; Hassan SI; Zalat RS
J Egypt Soc Parasitol; 2002 Apr; 32(1):59-68. PubMed ID: 12049270
[TBL] [Abstract][Full Text] [Related]
11. Praziquantel treatment of individuals exposed to Schistosoma haematobium enhances serological recognition of defined parasite antigens.
Mutapi F; Burchmore R; Mduluza T; Foucher A; Harcus Y; Nicoll G; Midzi N; Turner CM; Maizels RM
J Infect Dis; 2005 Sep; 192(6):1108-18. PubMed ID: 16107967
[TBL] [Abstract][Full Text] [Related]
12. Immune responses induced by repeated treatment do not result in protective immunity to Schistosoma haematobium: interleukin (IL)-5 and IL-10 responses.
van den Biggelaar AH; Borrmann S; Kremsner P; Yazdanbakhsh M
J Infect Dis; 2002 Nov; 186(10):1474-82. PubMed ID: 12404164
[TBL] [Abstract][Full Text] [Related]
13. Stage and species specificity of antigens encoded by two geographic strains of Schistosoma mansoni mRNA.
Blanton R; Horowitz S; Dos Reis MG; Rottman F; Andrade Z; Mahmoud AA
J Parasitol; 1986 Jun; 72(3):445-53. PubMed ID: 3091803
[TBL] [Abstract][Full Text] [Related]
14. Immunity and morbidity in infection due to Schistosoma haematobium.
Hagan P
Am J Trop Med Hyg; 1996 Nov; 55(5 Suppl):116-20. PubMed ID: 8940964
[TBL] [Abstract][Full Text] [Related]
15. Age-related antibody profiles in Schistosoma haematobium infections in a rural community in Zimbabwe.
Ndhlovu P; Cadman H; Vennervald BJ; Christensen NO; Chidimu M; Chandiwana SK
Parasite Immunol; 1996 Apr; 18(4):181-91. PubMed ID: 9223173
[TBL] [Abstract][Full Text] [Related]
16. Antibody responses in schistosomiasis haematobium in Somalia. Relation to age and infection intensity.
Hagi H; Huldt G; Loftenius A; Schröder H
Ann Trop Med Parasitol; 1990 Apr; 84(2):171-9. PubMed ID: 2116776
[TBL] [Abstract][Full Text] [Related]
17. Antibody to schistosomulum surface carbohydrate epitopes in subjects infected with Schistosoma haematobium.
Ali PO; Hagan P; Wilkins HA; Simpson AJ
Trans R Soc Trop Med Hyg; 1989; 83(3):358-61. PubMed ID: 2482557
[TBL] [Abstract][Full Text] [Related]
18. [Reinfection with Schistosoma haematobium and mansoni despite repeated praziquantel office treatment in Niger, Mali].
Dabo A; Doucoure B; Koita O; Diallo M; Kouriba B; Klinkert MQ; Doumbia S; Doumbo O
Med Trop (Mars); 2000; 60(4):351-5. PubMed ID: 11436587
[TBL] [Abstract][Full Text] [Related]
19. Urinary disease in 2 Dogon populations with different exposure to Schistosoma haematobium infection: progression of bladder and kidney diseases in children and adults.
Kouriba B; Traore HA; Dabo A; Sangare L; Guindo H; Keita AS; Reimert CM; van Dam GJ; Deelder AM; Doumbo O; Dessein AJ
J Infect Dis; 2005 Dec; 192(12):2152-9. PubMed ID: 16288382
[TBL] [Abstract][Full Text] [Related]
20. Serological speciation of human schistosome infections by ELISA with a panel of three antigens.
Turner P; Lalloo K; Bligh J; Armstrong M; Whitty CJ; Doenhoff MJ; Chiodini PL
J Clin Pathol; 2004 Nov; 57(11):1193-6. PubMed ID: 15509682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
